AcquisitionOther
Aurinia Pharmaceuticals Inc. acquired Kezar Life Sciences, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Aurinia Pharmaceuticals Inc. -> Kezar Life Sciences, Inc. · $6.955 per share
Acquisition through tender offer and merger via definitive agreement.
Open source record (SEC) ↗